| | 2180923-05-9 Basic information More.. |
| Product Name: | Bcl-2/Bcl-xl inhibitor 1 | | Synonyms: | Bcl-2/Bcl-xl inhibitor 1;Lisaftoclax;APG-2575;APG-2575 (lisaftoclax);Lisaftoclax (APG-2575;Benzamide, 4-[4-[[6-(4-chlorophenyl)spiro[3.5]non-6-en-7-yl]methyl]-1-piperazinyl]-N-[[4-[[(2S)-1,4-dioxan-2-ylmethyl]amino]-3-nitrophenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-;(S)-N-((4-(((1,4-Dioxan-2-yl)methyl)amino)-3-nitrophenyl)sulfonyl)-2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((6-(4-chlorophenyl)spiro[3.5]non-6-en-7-yl)methyl)piperazin-1-yl)benzamide;Lisaftoclax, 10 mM in DMSO | | CAS: | 2180923-05-9 | | MF: | C45H48ClN7O8S | | MW: | 882.42 | | EINECS: | | | Mol File: | 2180923-05-9.mol |  |
Bcl-2/Bcl-xl inhibitor 1 manufacturers
- Lisaftoclax
-
- US $187.00-595.00 / mg
- 2025-07-25
- CAS:2180923-05-9
- Min. Order:
- Purity: 98.16%
- Supply Ability: 10g
- Lisaftoclax
-
- US $187.00-595.00 / mg
- 2025-07-15
- CAS:2180923-05-9
- Min. Order:
- Purity: 98.16%
- Supply Ability: 10g
|
|
2180923-05-9
Recommend Suppliers |
|